课题基金 / 基金详情

TASK X22: Non-GLP Safety Study of multivalent toxoid S. aureus Vaccine (IBT-V02) in nonhuman primates for Integrated Biotherapeutics

TASK X22: Non-GLP Safety Study of multivalent toxoid S. aureus Vaccine (IBT-V02) in nonhuman primates for Integrated Biotherapeutics
任务 X22：用于综合生物治疗的多价类毒素金黄色葡萄球菌疫苗 (IBT-V02) 在非人灵长类动物中的非 GLP 安全性研究
批准号：
9537826
负责人：
RANDI HORNBACK
金额：
$36.38万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
项目状态：
已结题
起止时间：
2017-07-28 至 2018-04-30
来源：
https://reporter.nih.gov/project-details/9537826
关键词：
Antimicrobial ResistanceBiological Response Modifier TherapyBioterrorismClinicalCommunicable DiseasesContractsDevelopmentDrug resistanceEmerging Communicable DiseasesFeasibility StudiesPhaseSamplingServicesStaphylococcus aureusTestingToxicity TestsToxoidsVaccinesassay developmentefficacy testingevaluation/testingimmunogenicitynonhuman primatenovel vaccinespathogenproduct developmentsafety studysafety testingvaccine development

项目摘要

项目成果

RANDI HORNBACK的其他基金

相关文献

中文摘要
翻译
传染病疫苗和其他生物制品评估和测试服务(ETS)合同提供从早期可行性研究到I/II阶段材料生产的各种产品开发服务，包括分析开发、免疫原性和有效性测试、临床和非临床样本测试以及安全和毒性测试。这些服务将促进开发和引入新的疫苗和生物制品，以应对生物恐怖主义、抗药性病原体以及新出现和重新出现的传染病的潜在病原体。
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies